Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.58
-0.3800-6.38%
Post-market: 5.580.00000.00%19:18 EDT
Volume:1.90M
Turnover:10.63M
Market Cap:765.26M
PE:-1.46
High:5.85
Open:5.81
Low:5.49
Close:5.96
Loading ...
Apr 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report